GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Asensus Surgical Inc (FRA:2TX) » Definitions » 3-Year Book Growth Rate

Asensus Surgical (FRA:2TX) 3-Year Book Growth Rate : -38.10% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Asensus Surgical 3-Year Book Growth Rate?

Asensus Surgical's Book Value per Share for the quarter that ended in Mar. 2024 was €0.04.

During the past 12 months, Asensus Surgical's average Book Value per Share Growth Rate was -85.60% per year. During the past 3 years, the average Book Value per Share Growth Rate was -38.10% per year. During the past 5 years, the average Book Value per Share Growth Rate was -54.00% per year. During the past 10 years, the average Book Value per Share Growth Rate was -42.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.

During the past 13 years, the highest 3-Year average Book Value per Share Growth Rate of Asensus Surgical was 52.10% per year. The lowest was -64.30% per year. And the median was -23.20% per year.


Competitive Comparison of Asensus Surgical's 3-Year Book Growth Rate

For the Medical Devices subindustry, Asensus Surgical's 3-Year Book Growth Rate, along with its competitors' market caps and 3-Year Book Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Asensus Surgical's 3-Year Book Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Asensus Surgical's 3-Year Book Growth Rate distribution charts can be found below:

* The bar in red indicates where Asensus Surgical's 3-Year Book Growth Rate falls into.



Asensus Surgical 3-Year Book Growth Rate Calculation

This is the 3-year average growth rate of Book Value per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Book Value per Share growth rate.


Asensus Surgical  (FRA:2TX) 3-Year Book Growth Rate Explanation

Book Value per Share is the ratio of equity available to common shareholders divided by the shares outstanding. Book value per share effectively indicates a firm's net asset value on a per-share basis. It can be used by investors to gauge whether a stock price is undervalued by comparing it to the firm's market value per share. Theoretically, it is what the shareholders will receive if the company is liquidated.


Asensus Surgical 3-Year Book Growth Rate Related Terms

Thank you for viewing the detailed overview of Asensus Surgical's 3-Year Book Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Asensus Surgical (FRA:2TX) Business Description

Traded in Other Exchanges
Address
1 TW Alexander Drive, Suite 160, Durham, NC, USA, 27703
Asensus Surgical Inc is a medical device company that digitizes the interface between the surgeon and the patient to improve minimally invasive surgery through digital laparoscopy. It enables the use of advanced capabilities such as augmented intelligence, connectivity, and robotics in laparoscopy and seeks to address the current clinical, cognitive, and economic shortcomings in surgery. The Senhance Surgical System is the first machine vision system for use in robotic surgery, which is powered by the new Intelligent Surgical Unit that enables augmented intelligence in surgery and brings the benefits of digital laparoscopy to patients around the world. The company's single segment includes the research, development, and sale of medical device robotics to improve minimally invasive surgery.

Asensus Surgical (FRA:2TX) Headlines

No Headlines